Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation

American Journal of Cardiology

Volumn 83, Issue 2, 1999, Pages 286-288

  Nee, Robert ^b   Doppenschmidt, Dennis ^b   Donovan, Daniel J ^b   Andrews, Thomas C ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PHYTOMENADIONE; PLACEBO; WARFARIN;

ANTICOAGULATION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG INDICATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANALYSIS OF VARIANCE; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERNATIONAL NORMALIZED RATIO; VITAMIN K 1; WARFARIN;

EID: 0033556414     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00842-X     Document Type: Article

References (7)

1. Levine M, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108:276S-7290S.
2. 1. Thromb Haemost 1992;67:13-715.
3. Hirsh J, Dalen J, Deykin D, L P, Bussey H. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108:231S-7246S.
4. Andrews T, Peterson D, Doeppenschmidt D, Foster J, Lucca M, Deering J, LaVeau P. Complications of warfarin therapy monitored by the international normalized ratio versus the prothrombin time. Clin Cardiol 1995;18:80-782.
5. Rich E, Drage C. Severe complications of intravenous phytonadione therapy: two cases, with one fatality. Postgrad Med 1982;72:303-7306.
6. Shoshkes M, Rothfeld E, Jacobs M. Colloidally suspended phytonadione in bishydroxycoumarin-induced hypoprothrombinemia. Am J Cardiol 1961;8:72-75.
7. 1. Ann Intern Med 1997;125:959-962.